Systematic Evaluation Of Therapeutic Efficacy And Safety Of Traditional Chinese Medicine Injection (Tcmi) Combined With Oxaliplatin-Containing Chemotherapy In The Treatment Of Colorectal Cancer
Wenqi Huang,Zhu Yang,Fengxi Long,Li Luo,Jinghui Wang,Bing Yang,Dongxin Tang
2018-01-01
Abstract:Objective: This analysis was to evaluate the therapeutic efficacy and safety of traditional Chinese medicine injection (TCMI) combined with oxaliplatin-containing chemotherapy in the treatment of colorectal cancer. Methods: PubMed, Embase, Medline, Cochrane Library, Chinese Biomedical Literature Database, China National Knowledge Infrastructure (CNKI), China Knowledge Network, Weipu Chinese Journal Database, and Wanfang Database were searched, and randomized controlled trials (RCTs) concerning the combination treatment of TCMI and oxaliplatin chemotherapy were collected. Literature screening, data extraction, and methodology quality evaluation were performed. Meta-analysis was conducted with RevMan 5.3 software. Results: In total, 77 RCTs were included in this study, including 9 TCMI (i.e., ADI, BJOEI, CKSI, DLSI, KAI, KLTI, SQFZI, XAPI and XGDTI) and 6014 patients. Metaanalysis showed that, compared with the chemotherapy alone, the combination with the following 7 TCMI significantly elevated the efficacy rates: CKSI, ADI, SQFZI, BJOEI, DLSI, KAI and KLTI. In contrast, combination treatment with TCMIs of CKSI, ADI, SQFZI, BJOEI, DLSI, KAI, KLTI, or XAPI significantly improved quality of life for patients. Moreover, for treatment safety, compared with chemotherapy alone, the combination treatment with ADI, SQFZI, KAI, or KLTI significantly alleviated gastrointestinal reactions, and the combination treatment with CKSI, ADI, SQFZI, BJOEI, KAI, KLTI, or XAPI significantly ameliorated the bone marrow suppression. Notably, combination treatment with ADI also significantly reduced peripheral neurotoxicity. Conclusion: Oxaliplatin-containing chemotherapy combined with some TCMIs could exert therapeutic effects superior to chemotherapy alone in the treatment of colorectal cancer.